The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, dose-escalation phase 1b study of subcutaneous daratumumab with recombinant human hyaluronidase in patients with relapsed or refractory multiple myeloma (PAVO).
 
Hareth Nahi
Consulting or Advisory Role - Celgene; Janssen; Novartis; Takeda
Research Funding - Celgene; Janssen; MSD
 
Peter Hellemans
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tara J. Masterson
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Pamela L. Clemens
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Tahamtan Ahmadi
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jesus San Miguel
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Millennium; MSD; Novartis; Onyx
 
María-Victoria Mateos
Honoraria - Bristol-Myers Squibb; Celgene; Janssen
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda
Other Relationship - Celgene; Janssen
 
Saad Zafar Usmani
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Speakers' Bureau - Celgene; Millennium; Onyx
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics; Sanofi